Related references
Note: Only part of the references are listed.Impact of renal function on argatroban therapy during percutaneous coronary intervention
Marcie J. Hursting et al.
JOURNAL OF THROMBOSIS AND THROMBOLYSIS (2010)
Weight-Based Argatroban Dosing Nomogram for Treatment of Heparin-Induced Thrombocytopenia
Alexander J. Ansara et al.
ANNALS OF PHARMACOTHERAPY (2009)
Effects of Critical Illness and Organ Failure on Therapeutic Argatroban Dosage Requirements in Patients with Suspected or Confirmed Heparin-Induced Thrombocytopenia
Shaun P. Keegan et al.
ANNALS OF PHARMACOTHERAPY (2009)
Comparative Pharmacodynamics and Pharmacokinetics of Oral Direct Thrombin and Factor Xa Inhibitors in Development
Bengt I. Eriksson et al.
CLINICAL PHARMACOKINETICS (2009)
Reducing Harm Associated with Anticoagulation Practical Considerations of Argatroban Therapy in Heparin-Induced Thrombocytopenia
Marcie J. Hursting et al.
DRUG SAFETY (2009)
Rivaroxaban A Review of its Use for the Prevention of Venous Thromboembolism After Total Hip or Knee Replacement Surgery
Sean T. Duggan et al.
DRUGS (2009)
Reduced argatroban doses after coronary artery bypass graft surgery
William D. Hoffman et al.
ANNALS OF PHARMACOTHERAPY (2008)
What is the optimal anticoagulation level with argatroban during percutaneous coronary intervention?
Ignacio Cruz-Gonzalez et al.
BLOOD COAGULATION & FIBRINOLYSIS (2008)
Pharmacology and management of the vitamin K antagonists
Jack Ansell et al.
CHEST (2008)
Treatment and prevention of heparin-induced thrombocytopenia
Theodore E. Warkentin et al.
CHEST (2008)
Transition from argatroban to oral anticoagulation with phenprocoumon or acenocoumarol: Effect on coagulation factor testing
Jeanine M. Walenga et al.
CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS (2008)
Apixaban, an oral direct Factor Xa inhibitor: awaiting the verdict
Jennifer Carreiro et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2008)
Risk Factors for Major Bleeding in Patients With Heparin-induced Thrombocytopenia Treated With Argatroban: A Retrospective Study
Marcie J. Hursting et al.
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY (2008)
Dabigatran Etexilate: An Oral Direct Thrombin Inhibitor for Prophylaxis and Treatment of Thromboembolic Diseases
Brooke E. Baetz et al.
PHARMACOTHERAPY (2008)
Heparin-Induced Thrombocytopenia Clinical Studies and the Efficacy of Argatroban in Japan
Shigeki Miyata et al.
SEMINARS IN THROMBOSIS AND HEMOSTASIS (2008)
Argatroban Anticoagulation in Intensive Care Patients: Effects of Heart Failure and Multiple Organ System Failure
Susan M. Begelman et al.
JOURNAL OF INTENSIVE CARE MEDICINE (2008)
Effect of body mass index on argatroban therapy during percutaneous coronary intervention
Marcie J. Hursting et al.
JOURNAL OF THROMBOSIS AND THROMBOLYSIS (2008)
Efficacy and safety of argatroban with or without glycoprotein IIb/IIIa inhibitor in patients with heparin induced thrombocytopenia undergoing percutaneous coronary intervention for acute coronary syndrome
Ignacio Cruz-Gonzalez et al.
JOURNAL OF THROMBOSIS AND THROMBOLYSIS (2008)
Severe anaphylactic reaction after repeated intermittent exposure to lepirudin
Sidney A. Veach et al.
PHARMACOTHERAPY (2007)
Argatroban anticoagulation for heparin-induced thrombocytopenia in elderly patients
John R. Bartholomew et al.
DRUGS & AGING (2007)
Effect of renal function on argatroban therapy in heparin-induced thrombocytopenia
Louis M. Guzzi et al.
JOURNAL OF THROMBOSIS AND THROMBOLYSIS (2006)
Argatroban: Update
Robert W. Yeh et al.
AMERICAN HEART JOURNAL (2006)
Argatroban therapy in heparin-induced thrombocytopenia with hepatic dysfunction
Robert L. Levine et al.
CHEST (2006)
Argatroban anticoagulation in pediatric patients - A literature analysis
MJ Hursting et al.
JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY (2006)
A comparison of lepirudin and argatroban outcomes
MA Smythe et al.
CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS (2005)
Collaborative study on monitoring thrombin inhibitors lepirudin and methods to determine direct argatroban
E Gray et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2005)
Transitioning from argatroban to warfarin therapy in patients with heparin-induced thrombocytopenia
MJ Hursting et al.
CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS (2005)
Effect of argatroban on the activated partial thromboplastin time: a comparison of 21 commercial reagents
JL Francis et al.
BLOOD COAGULATION & FIBRINOLYSIS (2005)
Argatroban for anticoagulation during cardiopulmonary bypass in an infant
PC Dyke et al.
PEDIATRIC ANESTHESIA (2005)
Argatroban and renal replacement therapy in patients with heparin-induced thrombocytopenia
IY Tang et al.
ANNALS OF PHARMACOTHERAPY (2005)
Treatment of patients with a history of heparin-induced thrombocytopenia and anti-lepirudin antibodies with argatroban
H Job et al.
JOURNAL OF THROMBOSIS AND THROMBOLYSIS (2005)
Argatroban treatment for patients with intolerance to heparin and hirudin
B Kemkes-Matthes et al.
CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS (2005)
Systemic administration of Argatroban reduces secondary brain damage in a rat model of intracerebral hemorrhage: Histopathological assessment
T Nagatsuna et al.
CEREBROVASCULAR DISEASES (2005)
Argatroban anticoagulation in patients with a history of heparin-induced thrombocytopenia
WH Matthai et al.
THROMBOSIS RESEARCH (2005)
Stroke in patients with heparin-induced thrombocytopenia and the effect of argatroban therapy
MP LaMonte et al.
CRITICAL CARE MEDICINE (2004)
Effect of direct thrombin inhibitors, bivalirudin, lepirudin, and argatroban, on prothrombin time and INR values
RC Gosselin et al.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2004)
Small-molecule direct antithrombins: argatroban
J Fareed et al.
BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY (2004)
Treatment of heparin-induced thrombocytopenia - A critical review
J Hirsh et al.
ARCHIVES OF INTERNAL MEDICINE (2004)
Failure of argatroban anticoagulation during off-pump coronary artery bypass surgery
MA Cannon et al.
ANNALS OF THORACIC SURGERY (2004)
Argatroban as anticoagulant in cardiopulmonary bypass in an infant and attempted reversal with recombinant activated factor VII
S Malherbe et al.
ANESTHESIOLOGY (2004)
Pharmacokinetics and pharmacodynamics of argatroban in combination with a platelet glycoprotein IIB/IIIA receptor antagonist in patients undergoing percutaneous coronary intervention
DS Cox et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2004)
Argatroban anticoagulation in conjunction with glycoprotein IIb/IIIa inhibition in patients undergoing percutaneous coronary intervention: An open-label, nonrandomized pilot study
IK Jang et al.
JOURNAL OF THROMBOSIS AND THROMBOLYSIS (2004)
A prospective comparison of three argatroban treatment regimens during hemodialysis in end-stage renal disease
PT Murray et al.
KIDNEY INTERNATIONAL (2004)
Argatroban anticoagulation in patients with acute ischemic stroke (ARGIS-1) - A randomized, placebo-controlled safety study
MP LaMonte et al.
STROKE (2004)
Local delivery of argatroban for the prevention of restenosis after coronary balloon angioplasty - A prospective randomized pilot study
T Itoh et al.
CIRCULATION JOURNAL (2004)
Argatroban use during pediatric interventional cardiac catheterization
F Cetta et al.
CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS (2004)
Heparin-induced thrombocytopenia in the emergency department
RL Levine et al.
ANNALS OF EMERGENCY MEDICINE (2004)
Argatroban as an alternative to heparin in extracorporeal membrane oxygenation circuits
G Young et al.
PERFUSION-UK (2004)
Vascular surgery using argatroban in a patient with a history of heparin-induced thrombocytopenia
Y Tokuda et al.
CIRCULATION JOURNAL (2003)
Argatroban anticoagulation in patients with heparin-induced thrombocytopenia
BE Lewis et al.
ARCHIVES OF INTERNAL MEDICINE (2003)
Effects of argatroban as an anticoagulant for haemodialysis in patients with antithrombin III deficiency
K Ota et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2003)
Successful use of argatroban as a heparin substitute during cardiopulmonary bypass: Heparin-induced thrombocytopenia in a high-risk cardiac surgical patient
JT Edwards et al.
ANNALS OF THORACIC SURGERY (2003)
Hemostatic analysis of a patient undergoing off-pump coronary artery bypass surgery with argatroban anticoagulation
DR Kieta et al.
ANESTHESIA AND ANALGESIA (2003)
Argatroban as an alternative anticoagulant for patients with heparin allergy during coronary bypass surgery
H Ohno et al.
HEART AND VESSELS (2003)
Heparin-induced thrombocytopenia and cardiopulmonary bypass:: Perioperative argatroban use
N Lubenow et al.
ANNALS OF THORACIC SURGERY (2003)
How I treat heparin-induced thrombocytopenia and thrombosis
BM Alving
BLOOD (2003)
Argatroban anticoagulation during percutaneous coronary intervention in patients with heparin-induced thrombocytopenia
BE Lewis et al.
CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS (2002)
Monitoring of argatroban in ARG310 study: Potential recommendations for its use in interventional cardiology
O Iqbal et al.
CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS (2002)
Argatroban therapy does not generate antibodies that alter its anticoagulant activity in patients with heparin-induced thrombocytopenia
JM Walenga et al.
THROMBOSIS RESEARCH (2002)
Practical issues in the development of argatroban: A perspective
J Fareed et al.
PATHOPHYSIOLOGY OF HAEMOSTASIS AND THROMBOSIS (2002)
Argatroban and alteplase in patients with acute myocardial infarction:: The ARGAMI study
F Vermeer et al.
JOURNAL OF THROMBOSIS AND THROMBOLYSIS (2000)
Clinical application of argatroban as an alternative anticoagulant for extracorporeal circulation
T Kawada et al.
HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA (2000)
The pharmacokinetics and pharmacodynamics of argatroban: Effects of age, gender, and hepatic or renal dysfunction
SK Swan et al.
PHARMACOTHERAPY (2000)
Share Paper
